Inhibrx Correlations
INBX Stock | USD 16.89 0.32 1.86% |
The correlation of Inhibrx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inhibrx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inhibrx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Modest diversification
The correlation between Inhibrx and NYA is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and NYA in the same portfolio, assuming nothing else is changed.
Inhibrx |
The ability to find closely correlated positions to Inhibrx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inhibrx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inhibrx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inhibrx to buy it.
Moving against Inhibrx Stock
0.55 | OBIO | Orchestra BioMed Holdings | PairCorr |
0.53 | NTRB | Nutriband Financial Report 14th of June 2024 | PairCorr |
0.51 | NTRBW | Nutriband Warrant | PairCorr |
Related Correlations Analysis
Please specify at least 3 valid symbols having historical data to build a meaningful correlation cloud. You can use symbol search above to locate your securities.
Inhibrx Corporate Management
Leah JD | Corporate VP | Profile | |
Mark Lappe | Chairman, Founder | Profile | |
Charbel PharmD | Vice Planning | Profile | |
BS CPA | Chief Officer | Profile | |
Jeffrey Jensen | Executive Officer | Profile | |
Brendan Eckelman | Founder Officer | Profile | |
Carlos Bais | Executive Sciences | Profile |
Additional Tools for Inhibrx Stock Analysis
When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.